Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial-Reference-Cited by-同舟云学术

Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial

Published:2019-04 Issue:10180 Volume:393 Page:1505-1516
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Gazzard Gus,Konstantakopoulou Evgenia,Garway-Heath David,Garg Anurag,Vickerstaff Victoria,Hunter Rachael,Ambler Gareth,Bunce Catey,Wormald Richard,Nathwani Neil,Barton Keith,Rubin Gary,Buszewicz Marta,Ambler Gareth,Barton Keith,Bourne Rupert,Broadway David,Bunce Catey,Buszewicz Marta,Davis Amanda,Garg Anurag,Garway-Heath David,Gazzard Gus,Hunter Rachael,Jayaram Hari,Jiang Yuzhen,Konstantakopoulou Evgenia,Lim Sheng,Liput Joanna,Manners Timothy,Morris Stephen,Nathwani Neil,Rubin Gary,Strouthidis Nicholas,Vickerstaff Victoria,Wilson Sarah,Wormald Richard,Zhu Haogang

Publisher

Elsevier BV

Subject

General Medicine

Reference34 articles.

1. Risk of falls and motor vehicle collisions in glaucoma;Haymes;Invest Ophthalmol Vis Sci,2007

2. Glaucoma and on-road driving performance;Haymes;Invest Ophthalmol Vis Sci,2008

3. Leading causes of certification for blindness and partial sight in England & Wales;Bunce;BMC Public Health,2006

4. The number of people with glaucoma worldwide in 2010 and 2020;Quigley;Br J Ophthalmol,2006

5. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial;Garway-Heath;Lancet,2015

Cited by 367 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preservatives and ocular surface disease: A review;The Ocular Surface;2024-10

2. The Glaucoma Intensive Treatment Study (GITS): A Randomized Controlled Trial Comparing Intensive and Standard Treatment on 5 Years Visual Field Development;American Journal of Ophthalmology;2024-10

3. Nanomedicine in glaucoma treatment; Current challenges and future perspectives;Materials Today Bio;2024-10

4. 3-year safety and efficacy results of PreserFlo™ Microshunt in glaucoma patients: A multicentre European cohort study;AJO International;2024-10

5. Standard of Care for First-line Therapy in Newly Diagnosed Glaucoma and Update on SLT from the LiGHT Trial;Canadian Eye Care Today;2024-08-30